相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype
Elena Bresin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
C3 glomerulopathy: consensus report
Matthew C. Pickering et al.
KIDNEY INTERNATIONAL (2013)
Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome
Mathieu Lemaire et al.
NATURE GENETICS (2013)
Eculizumab in Atypical Hemolytic-Uremic Syndrome
Troels Ring
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
C. M. Legendre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Atypical Hemolytic Uremic Syndrome
David Kavanagh et al.
SEMINARS IN NEPHROLOGY (2013)
A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function
Lubka T. Roumenina et al.
BLOOD (2012)
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
Marina Noris et al.
NATURE REVIEWS NEPHROLOGY (2012)
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
Julien Zuber et al.
NATURE REVIEWS NEPHROLOGY (2012)
Age-Related Penetrance of Hereditary Atypical Hemolytic Uremic Syndrome
Maren Sullivan et al.
ANNALS OF HUMAN GENETICS (2011)
Alternative complement pathway assessment in patients with atypical HUS
Lubka T. Roumenina et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis
Marina Morigi et al.
JOURNAL OF IMMUNOLOGY (2011)
The Development of Atypical Hemolytic Uremic Syndrome Depends on Complement C5
Elena Goicoechea de Jorge et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Atypical hemolytic uremic syndrome
Chantal Loirat et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome
Marcus Weitz et al.
PEDIATRIC NEPHROLOGY (2011)
Epidemiological Approach to Identifying Genetic Predispositions for Atypical Hemolytic Uremic Syndrome
Maren Sullivan et al.
ANNALS OF HUMAN GENETICS (2010)
Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome
Iain Moore et al.
BLOOD (2010)
Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype
Marina Noris et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation
Ruben Martinez-Barricarte et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome
Lubka T. Roumenina et al.
BLOOD (2009)
Thrombomodulin Mutations in Atypical Hemolytic-Uremic Syndrome
Mieke Delvaeye et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MEDICAL PROGRESS Atypical Hemolytic-Uremic Syndrome
Marina Noris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
Veronique Fremeaux-Bacchi et al.
BLOOD (2008)
The complement factor h R1210C mutation is associated with atypical hemolytic uremic syndrome
Ruben Martinez-Barricarte et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Where next with atypical hemolytic uremic syndrome?
T. Sakari Jokiranta et al.
MOLECULAR IMMUNOLOGY (2007)
Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains
Matthew C. Pickering et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome
Elena Goicoechea de Jorge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)
C. Licht et al.
KIDNEY INTERNATIONAL (2006)
Platelet activation leads to activation and propagation of the complement system
I del Conde et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H
P Sánchez-Corral et al.
MOLECULAR IMMUNOLOGY (2004)
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome
T Manuelian et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition
A Richards et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
分享论文
